AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Aeglea Biotherapeutics Inc. (AGLE) on Thursday reported a loss of $40.1 million in its third quarter.
On a per-share basis, the Austin, Texas-based company said it had a loss of $9.34. Losses, adjusted for non-recurring costs, came to $3.43 per share.
Aeglea shares have declined 16% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.47, a decrease of 71% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE